Discovery and Preclinical Profile of ALG-097558, a SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19
Sign up to read this post
Join Now
Previous
Previous
Virologic Response and Safety After Oral Administration of PF-07817883, a Novel SARS-CoV-2 Mpro inhibitor, in Nonhospitalized Adults With Symptomatic COVID-19
Next
Next